J0738 Insurance Policy Changes

HCPCS J0738 is officially defined as "Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)." HCPCS J0738 is referenced in 8 tracked payer policy changes from Blue Cross Blue Shield of Vermont, Florida Blue, and 5 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J0738 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.